No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents, Hormonal / administration & dosage*
-
Antineoplastic Agents, Hormonal / adverse effects
-
Antineoplastic Agents, Hormonal / blood
-
Antineoplastic Agents, Hormonal / pharmacokinetics*
-
Chromatography, High Pressure Liquid
-
Drug Administration Schedule
-
Estrogen Receptor Modulators / administration & dosage*
-
Estrogen Receptor Modulators / adverse effects
-
Estrogen Receptor Modulators / blood
-
Estrogen Receptor Modulators / pharmacokinetics*
-
Feasibility Studies
-
Humans
-
Multiple Myeloma / drug therapy*
-
Receptors, Estrogen / metabolism
-
Receptors, Progesterone / metabolism
-
Tamoxifen / administration & dosage*
-
Tamoxifen / adverse effects
-
Tamoxifen / blood
-
Tamoxifen / pharmacokinetics*
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Hormonal
-
Estrogen Receptor Modulators
-
Receptors, Estrogen
-
Receptors, Progesterone
-
Tamoxifen